AstraZeneca shares dive on big day for FTSE results
AstraZeneca’s plummeting share price was the biggest story in a morning flooded with company results on Thursday, with the FTSE index holding steady despite a wobbly start for stocks.
AstraZeneca’s plummeting share price was the biggest story in a morning flooded with company results on Thursday, with the FTSE index holding steady despite a wobbly start for stocks.
|
|
Brewin Dolphin reported record inflows of £1.1bn into its discretionary funds over the last six months as it completed the acquisition of Duncan Lawrie Asset Management.
|
|